Overview

Efficacy Study of Two Formulations of Erythropoietin

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
A double-blind, randomized trial aimed to compare the efficacy of two formulations of erythropoietin in patients with chronic renal failure on hemodialysis
Phase:
Phase 3
Details
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Collaborators:
Institute of Technology Immunobiologicals Oswaldo Cruz Foundation / BioManguinhos
Oswaldo Cruz Foundation
State Department of Health of Rio Grande do Sul
Treatments:
Epoetin Alfa